These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 3102630)
1. Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosa. Livermore DM; Yang YJ J Infect Dis; 1987 Apr; 155(4):775-82. PubMed ID: 3102630 [TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms. Chen HY; Livermore DM J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068 [TBL] [Abstract][Full Text] [Related]
3. Chromosomal beta-lactamase expression and resistance to beta-lactam antibiotics in Proteus vulgaris and Morganella morganii. Yang YJ; Livermore DM Antimicrob Agents Chemother; 1988 Sep; 32(9):1385-91. PubMed ID: 3058021 [TBL] [Abstract][Full Text] [Related]
4. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis. Shannon K; Phillips I J Antimicrob Chemother; 1986 Dec; 18 Suppl E():15-22. PubMed ID: 3102451 [TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa beta-lactamase as a defence against azlocillin, mezlocillin and piperacillin. Jacobs JY; Livermore DM; Davy KW J Antimicrob Chemother; 1984 Sep; 14(3):221-9. PubMed ID: 6436226 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of beta-lactam resistance in British isolates of Pseudomonas aeruginosa. Williams RJ; Livermore DM; Lindridge MA; Said AA; Williams JD J Med Microbiol; 1984 Jun; 17(3):283-93. PubMed ID: 6327987 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods. Livermore DM Eur J Clin Microbiol; 1987 Aug; 6(4):439-45. PubMed ID: 3311738 [TBL] [Abstract][Full Text] [Related]
8. Activity of cefpirome (HR810) against Pseudomonas aeruginosa strains with characterised resistance mechanisms to beta-lactam antibiotics. Gargalianos P; Oppenheim BA; Skepastianos P; Livermore DM; Williams RJ J Antimicrob Chemother; 1988 Dec; 22(6):841-8. PubMed ID: 3149631 [TBL] [Abstract][Full Text] [Related]
9. Cephalosporin resistance in Pseudomonas aeruginosa, with special reference to the proposed trapping of antibiotics by beta-lactamase. Livermore DM; Williams JD; Davy KW Chemioterapia; 1985 Feb; 4(1):28-35. PubMed ID: 3921264 [TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics. Philippon A Chemioterapia; 1985 Dec; 4(6):424-8. PubMed ID: 3938346 [TBL] [Abstract][Full Text] [Related]
11. Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactams. Babini GS; Yuan M; Livermore DM Antimicrob Agents Chemother; 1998 May; 42(5):1168-75. PubMed ID: 9593145 [TBL] [Abstract][Full Text] [Related]
12. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms. Livermore DM; Yang YJ J Antimicrob Chemother; 1989 Sep; 24 Suppl A():149-59. PubMed ID: 2553657 [TBL] [Abstract][Full Text] [Related]
13. Beta-lactamase-mediated resistance to extended spectrum cephalosporins among clinical isolates of Pseudomonas aeruginosa. Ben-Mahrez K; Rejiba S; Belhadj C; Belhadj O Res Microbiol; 1999; 150(6):403-6. PubMed ID: 10466408 [TBL] [Abstract][Full Text] [Related]